400-921-8278
| Catalog_no | ADMC1236 |
| Product_name | IPI-549 |
| Category | 抑制剂与激动剂 |
| Size | 10mg/50mg/100mg |
| Price | 1660.00/3880.00/7000.00 |
| Specificity | Target: PI3K. Fields: IPI-549 is an orally administered immuno-oncology development candidate that selectively inhibits PI3K-gamma. IC50: 16 nM (PI3Kγ), 3.2 μM (PI3Kα), 3.5 μM (PI3Kβ), >8.4 μM (PI3Kδ)[1] |
| Dilution | IC50: 16 nM (PI3Kγ), 3.2 μM (PI3Kα), 3.5 μM (PI3Kβ), >8.4 μM (PI3Kδ)[1] |
| Purification | >98% |
| Concentration | 靶点：PI3K;IC50： 16 nM (PI3Kγ), 3.2 μM (PI3Kα), 3.5 μM (PI3Kβ), >8.4 μM (PI3Kδ)[1] |
| Storage_stability | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername | IPI549,IPI 549 |
| Observed_band | 528.2 |
| Notes | IPI-549 is an orally administered immuno-oncology development candidate that selectively inhibits PI3K-gamma. IC50: 16 nM (PI3Kγ), 3.2 μM (PI3Kα), 3.5 μM (PI3Kβ), >8.4 μM (PI3Kδ)[1] |
| Instructions | 
查看与下载 |
| Share |
 |
Copyright © 2021 苏州博特龙免疫技术有限公司 版权所有 ，苏ICP备2021013855号-1
苏公网安备32050702011981号 
